Lenart Lukáš M.Sc.

E-mail: lukas.lenart01@upol.cz

Skupiny: BAKALÁŘSKÝ STUDENT, DOKTORSKÝ STUDENT, LEM, MAGISTERSKÝ STUDENT

Molecular basis of rare diseases and molecular targets

Specializace: Molekulární a translační medicína

Vedoucí: Hajdúch Marián M.D., Ph.D.

Stav: Ongoing od 2023.

CRISPR/Cas9 as a tool for the development of a cystic fibrosis model for high throughput screening of compounds

Vedoucí: Ondra Martin M.Sc.

Stav: Absolvoval od 2021 do 2023.

Analysis of antiparasitic activity of novel compounds

Vedoucí: Schadich Ermin Ph.D.

Stav: Graduated od 2018 do 2021.

ZAJDEL, P., V. LOBAZ, M. ONDRA, R. KONEFAL, O. MORAVEC, O. POP GEORGIEVSKI, J. PANEK, D. KALITA, B. SIKORA DOBROWOLSKA, L. LENART, M. HAJDÚCH, M. HRUBY, M. PRUSZYNSKI

May the target be with you: polysaccharide-coated upconverting nanoparticles for macrophage targeting. Nanoscale. 2025, 17(43), 25120-25135, ISSN: 2040-3364 , PMID: 41123462, PDF.

ONDRA, M., L. LENART, A. CENTORAME, D. DUMUT, A. HE, S. ZAIDI, J. HANRAHAN, J. DE SANCTIS, D. RADZIOCH, M. HAJDÚCH

CRISPR/Cas9 bioluminescence-based assay for monitoring CFTR trafficking to the plasma membrane. Life Science Alliance. 2023, 7(1), e202302045, ISSN: 2575-1077, PMID: 37918963,

Lenart Lukáš M.Sc.

Doktorské studium

Magisterské studium

Bakalářské studium

Journals